1. Gilead’s Kite files for FDA approval of second CAR-T — Merck’s Keytruda gets win for triple-negative breast cancer — The House votes on the Lower Drug Cost Now Act — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Keryx Biopharmaceuticals

Keryx Biopharmaceuticals


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    0
    Views:
    1,188
  2. anonymous
    Replies:
    9
    Views:
    2,563
  3. anonymous
    Replies:
    4
    Views:
    1,891
  4. Irate Shareholder
    Replies:
    9
    Views:
    2,884
  5. anonymous
    Replies:
    0
    Views:
    751
  6. anonymous
    Replies:
    8
    Views:
    2,033
  7. anonymous
    Replies:
    27
    Views:
    5,242
  8. anonymous
    Replies:
    20
    Views:
    6,296
  9. anonymous
    Replies:
    1
    Views:
    1,063
  10. anonymous
    Replies:
    4
    Views:
    1,230
  11. anonymous
    Replies:
    1
    Views:
    1,251
  12. anonymous
    Replies:
    23
    Views:
    6,922
  13. Angry Shareholder
    Replies:
    6
    Views:
    2,083
  14. anonymous
    Replies:
    6
    Views:
    4,379
  15. anonymous
    Replies:
    0
    Views:
    842
  16. anonymous
    Replies:
    203
    Views:
    30,032
  17. anonymous
    Replies:
    19
    Views:
    7,609
  18. anonymous
    Replies:
    177
    Views:
    43,285
  19. anonymous
    Replies:
    3
    Views:
    1,636
  20. anonymous
    Replies:
    7
    Views:
    1,673

Thread Display Options

Loading...